These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26714363)

  • 1. Compounding with Silicones.
    Allen LV
    Int J Pharm Compd; 2015; 19(3):223-30. PubMed ID: 26714363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in silicones for topical and transdermal drug delivery.
    Aliyar H; Schalau G
    Ther Deliv; 2015 Jul; 6(7):827-39. PubMed ID: 26228774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silicones in dermatological topical drug formulation: Overview and advances.
    Sounouvou HT; Lechanteur A; Piel G; Evrard B
    Int J Pharm; 2022 Sep; 625():122111. PubMed ID: 35973590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vapor-Phase Hydrogen Peroxide Uptake by Silicone Tubing and Primary Packaging Components during Protein Drug Product Aseptic Filling: Impact of Pretreatment and Sterilization Process.
    Eisner DR; Hubbard A; Eppler K; Tegoulia V; Maa YF
    PDA J Pharm Sci Technol; 2019; 73(5):443-458. PubMed ID: 31004039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining drug hydrophobicity in continuous wet granulation within a twin screw extruder.
    Li H; Thompson MR; O'Donnell KP
    Int J Pharm; 2015 Dec; 496(1):3-11. PubMed ID: 26232701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation and Particle Formation of Therapeutic Proteins in Contact With a Novel Fluoropolymer Surface Versus Siliconized Surfaces: Effects of Agitation in Vials and in Prefilled Syringes.
    Teska BM; Brake JM; Tronto GS; Carpenter JF
    J Pharm Sci; 2016 Jul; 105(7):2053-65. PubMed ID: 27233685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New formulations in dermatology].
    Fredon L; Mallard C
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S30-6. PubMed ID: 17563712
    [No Abstract]   [Full Text] [Related]  

  • 9. Introducing the Alba
    Chillon A; Pace A; Zuccato D
    PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
    Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
    J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
    Rayaprolu BM; Strawser JJ; Anyarambhatla G
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Drug Formulation Variables on Silicone Oil Structure and Functionality of Prefilled Syringe System.
    Shi GH; Gopalrathnam G; Shinkle SL; Dong X; Hofer JD; Jensen EC; Rajagopalan N
    PDA J Pharm Sci Technol; 2018; 72(1):50-61. PubMed ID: 29030531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of syringe surfaces on protein formulations.
    Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
    J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silicones as nonocclusive topical agents.
    De Paepe K; Sieg A; Le Meur M; Rogiers V
    Skin Pharmacol Physiol; 2014; 27(3):164-71. PubMed ID: 24457536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical methods for improving flow properties of active pharmaceutical ingredients.
    Pingali KC; Saranteas K; Foroughi R; Muzzio FJ
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1460-9. PubMed ID: 19929205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological functions of lipid excipients and the implications for pharmaceutical products development.
    Wasan KM
    J Pharm Sci; 2009 Feb; 98(2):379-82. PubMed ID: 18484625
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basics of Compounding with Dilutions and Concentrates.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):39-45. PubMed ID: 28346197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of silicone microspheres by emulsion polymerization: application to the encapsulation of a hydrophilic drug.
    Kedzierewicz F; Darme X; Etienne A; Lemut J; Hoffman M; Maincent P
    J Microencapsul; 1998; 15(2):227-36. PubMed ID: 9532528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.